23^rd Global Biomarkers and Clinical Research Summit

Welcome Message

Dear Esteemed Participants,

On behalf of the organizing committee, we are delighted to welcome you to the 23^rd Global Biomarkers and Clinical Research Summit, scheduled for August 24–25, 2027, in Paris, France.

This international summit brings together researchers, clinicians, academicians, pharmaceutical and biotechnology professionals, and industry experts to share knowledge and discuss the latest developments in biomarker science and clinical research.

Under the theme “Integrating Biomarker Discovery, AI, and Clinical Research for Better Healthcare,” the summit aims to highlight advances in biomarker discovery, genomic research, liquid biopsy, precision medicine, diagnostic innovation, and clinical applications. It provides a valuable platform for presenting research findings, exchanging scientific ideas, and exploring innovative approaches to disease detection, treatment monitoring, and personalized healthcare.

We encourage all participants to engage in scientific discussions, share their expertise, establish meaningful collaborations, and contribute to the advancement of biomarker research and clinical practice.

We look forward to your valuable participation and to welcoming you for an enriching experience of scientific exchange, innovation, and global collaboration.

Warm regards,
Organizing Committee
23^rd Global Biomarkers and Clinical Research Summit

About Conference

The 23^rd Global Biomarkers and Clinical Research Summit, scheduled for August 24–25, 2027, in Paris, France, will bring together researchers, scientists, clinicians, academicians, pharmaceutical professionals, biotechnology experts, and industry leaders to share knowledge and explore recent advancements in biomarker research and clinical applications.

The summit will focus on the discovery, development, validation, and clinical application of biomarkers across various fields, including oncology, neurology, cardiovascular medicine, immunology, and metabolic disorders. Key areas of discussion will include genomics, proteomics, metabolomics, liquid biopsy, digital biomarkers, artificial intelligence, precision medicine, clinical diagnostics, and biomarker-guided drug development.

The scientific program will provide opportunities for keynote presentations, oral and poster sessions, expert discussions, and knowledge exchange on emerging technologies, research methodologies, clinical applications, and regulatory challenges in biomarker development. The summit aims to encourage collaboration between academic institutions, research organizations, healthcare professionals, and industry representatives.

Whether you are a researcher exploring new biomarkers, a clinician improving diagnostic and treatment approaches, an academic sharing scientific findings, or an industry professional developing innovative diagnostic solutions, this summit offers a platform to present your work, exchange ideas, establish professional connections, and contribute to the advancement of biomarker science and clinical research.

CONFERENCE AGENDA:

Registration & Kit Collection: Delegates begin by collecting conference kits, name badges, and agendas. Staff will be available to assist and guide participants through the event schedule.

Inaugural Session & Opening Remarks: The summit opens with welcoming remarks from the organizing committee, followed by keynote lectures from distinguished leaders in biomarker science and translational medicine.

Scientific Sessions & Presentations: Parallel sessions will cover a broad range of topics, including biomarker validation, proteomics, metabolomics, clinical assay development, companion diagnostics, and regulatory pathways. Oral and poster presentations will showcase pioneering studies and industry-driven innovations.

Networking Breaks & Exhibitions: Coffee breaks and poster walks offer valuable opportunities to meet peers, discuss research, and explore exhibitor displays from diagnostics, pharma, and biotech organizations.

Conference Lunch & Award Ceremony: Delegates will enjoy interactive lunches and networking discussions. Awards will be presented for the best oral and poster presentations on the concluding day.

Optional Activities: Participants may join guided tours or networking dinners, blending scientific collaboration with the cultural charm of Paris. 

Why to Attend?

Attending this conference offers a blend of knowledge, networking, and opportunity:

• Gain deep insights into the latest global biomarkers and clinical research strategies and innovations.
• Engage with decision-makers, researchers, and clinical research leaders from across Europe and beyond.
• Strengthen professional networks to support collaborations, research partnerships, and institutional linkages.
• Present your work to an international audience and enhance your academic and professional visibility.
• Access sessions focused on cutting-edge topics such as biomarker validation, proteomics, metabolomics, clinical assay development, companion diagnostics, and regulatory pathways.
• Participate in workshops that translate evidence into practice, offering tools that can be implemented in real-world settings.

Experience the cultural richness of Paris while being part of one of Europe’s most impactful health conferences

Participation / Presentation Options

To ensure accessibility for global researchers and clinical professionals, the Summit offers multiple participation formats designed to support scientific exchange, visibility, and collaboration.

Oral Presentation: Showcase comprehensive studies, clinical trial findings, biomarker discovery research, molecular diagnostics, or innovative laboratory methodologies. Oral presenters participate in interactive Q&A sessions with scientific experts.

Poster Presentation: Ideal for early-stage studies, pilot data, method development, and exploratory biomarker work. Presenters engage with delegates during dedicated poster viewing and networking segments.

Virtual Presentation: A flexible option for participants unable to travel. Present your work online and receive equal recognition, certificates, and publication benefits as onsite presenters.

Delegate Participation: For professionals who wish to attend without presenting. Delegates gain full access to all scientific sessions, keynote talks, workshops, and networking activities.

Exhibitor & Sponsorship Opportunities: Designed for biotech firms, diagnostic companies, CROs, universities, and healthcare technology providers. Exhibitors can showcase products, services, and innovations to a global audience.

• Learn from global leaders in biomarkers, precision medicine, molecular diagnostics, and translational research.
• Gain insights from keynote lectures, scientific sessions, expert panels, and hands-on workshops.
• Explore advancements in multi-omics, liquid biopsy technologies, AI-driven diagnostics, and clinical data science.

Global Networking Opportunities:

• Meet researchers, clinicians, industry experts, and innovators from over 40 countries.
• Build partnerships for joint projects, publications, grants, and institutional collaborations.
• Connect with peers, mentors, and future employers in both academic and industrial settings.

Presentation & Publication Advantages:

• Present your research through Oral, Poster, or Virtual formats.
• Receive:
• Certificate of Presentation
• Certificate of Participation
• Official conference recognition
• Selected abstracts may be included in conference proceedings or associated publications.
• Early submissions receive priority scheduling and enhanced visibility.

Career Growth & Professional Development:

• Strengthen your academic profile and CV with participation in a globally recognized summit.
• Gain insights into clinical research trends, biomarker validation workflows, and regulatory pathways.
• Attend sessions on scientific leadership, research communication, and healthcare innovation.

Diverse Session Formats:

• Keynote sessions
• Scientific oral presentations
• Poster exhibitions
• Panel debates
• Specialized technical workshops
• Industry demonstrations

Each session is designed to encourage interactive learning and cross-disciplinary collaboration.

Resources & Post-Conference Access:

• Access recorded sessions (virtual and select categories).
• Download speaker presentations, session summaries, and conference materials.
• Continue networking through post-event communication channels.

Visa Assistance & Flexible Participation:

• Receive official invitation letters for visa processing.
• If travel is not possible, participants may switch to virtual mode or transfer registration as per policy.
• Hybrid options ensure participation regardless of travel restrictions.

Institutional & Organizational Benefits:

• Enhance institutional visibility through international representation.
• Explore collaboration opportunities with global research groups and industry partners.
• Identify new technologies, clinical tools, and research advancements for institutional growth.

Cultural & Experiential Value (Onsite Participants):

• Experience Paris—its culture, science, cuisine, and historic landmarks.
• Take part in networking dinners, social gatherings, and optional city tours.
• Combine scientific enrichment with a memorable international travel experience.

Certification & Recognition:

All participants receive:

• Certificate of Participation
• Certificate of Presentation (for presenters)
• Official endorsement from the 23rd Global Biomarkers and Clinical Research Summit

These recognitions support academic portfolios, job applications, and future grant proposals.

Abstract Review Process

Our abstract review process ensures academic rigor and fair evaluation:

Submission: Authors submit abstracts through the official online portal.

Pre-Screening: The editorial team verifies topic relevance, clarity, and structure.

Double-Blind Evaluation: Each abstract is reviewed by two independent experts specializing in biomarkers and clinical research, or related fields.

Scoring Criteria:

• Scientific merit and originality
• Practical implications for biomarkers
• Methodological accuracy
• Relevance to conference themes

Decision & Notification: Accepted abstracts are assigned to Oral, Poster, or Virtual Presentation categories. Feedback and revision suggestions may be offered where applicable.

Early Acceptance Advantage: Early submissions are given priority in program scheduling, allowing authors to secure preferred presentation slots.

VISA Process      

We support all international participants in successfully completing their visa application process. Once your registration is confirmed, the organizing committee will provide:

• A formal Invitation Letter
• Accommodation confirmation (if booked through the conference)
• A detailed conference schedule
• Proof of registration and payment

These documents assist in meeting the requirements of the French Embassy or Consulate in your region.

General Visa Requirements:

Participants may be asked to provide:

• A valid passport
• Completed visa application form
• Invitation letter from the conference
• Proof of accommodation and travel itinerary
• Registration confirmation

We strongly recommend applying 6–8 weeks in advance to avoid last-minute complications.

In Case of Visa Rejection: Refund & Participation Options:

We understand that visa outcomes vary from country to country. Therefore, our policy is designed to support you:

• If your visa is rejected, you may switch to Virtual Presentation or Virtual Participation without any deduction.
• If you prefer to request a refund, the organizing committee will process it after receiving the official visa rejection letter from the embassy or consulate.
• Refund requests must be submitted within 10 days of receiving the rejection notice.
• Refunds will be processed within 2–3 weeks or after the conference, depending on the circumstances.
• Registration can also be transferred to the next edition of the conference without additional fees if preferred.

This ensures that your research and contribution remain part of the scientific program—even if you cannot travel physically.

Market Analysis

The global biomarkers market continues to grow rapidly, driven by the increasing demand for precision medicine, early disease detection, and targeted therapeutics.

• The global biomarkers market is projected to surpass USD 180 billion by 2030, growing at a CAGR of over 12%.
• Cancer biomarkers dominate the sector, with rising applications in immunotherapy and liquid biopsy technologies.
• Neurological and cardiovascular biomarkers are witnessing significant investment due to advancements in imaging and omics-based diagnostics.
• AI and machine learning are transforming data integration and biomarker discovery pipelines, enabling predictive analytics in clinical decision-making.
• Pharmaceutical and biotech collaborations are expanding, focusing on companion diagnostics and drug development efficiency.

This summit provides an ideal platform for researchers, investors, and industry leaders to align with emerging market trends, foster global partnerships, and accelerate translational biomarker research from bench to bedside